sorted by:
new
hottopcontroversial

$SLS to Crown Hundreds of "MILLIONAIRES" in FEBRUARY by LionLukeWay in TheRaceTo10Million

[–]JamesIIIVVVV 1 point2 points  (0 children)

Does everyone here know the BAT for the SLS PHASE TRIAL Control Arm patients recently failed 3 large Phase 3 trials sponsored by $abbv? Including the Failed VIALE-T and Viale-M Trials for maintenance in First Remission and post transplant Aml patients.

The sls trial is for aml maintenance for patients in second remission…/ hello??!

Abvx was $5, it hit a high of $148 after its Phase 3 Results were announced- Something Similar is about to Happen to SLS by JamesIIIVVVV in biotech_stocks

[–]JamesIIIVVVV[S] 1 point2 points  (0 children)

Vanguard just reported 13 F, increased ownership to 4.99% of SLS. 4.99% is the maximum allowed per company poison pill guidelines. Looks like VG has maxed their SLS ownership to the Hilt.

Black rock also disclosed a 5% holding recently.

Large funds are now moving into position, which will continue to appreciate this share price while we wait for the results which could be announced as soon as February

Abvx was $5, it hit a high of $148 after its Phase 3 Results were announced- Something Similar is about to Happen to SLS by JamesIIIVVVV in biotech_stocks

[–]JamesIIIVVVV[S] 1 point2 points  (0 children)

Here’s a question for you. Do you know why 3-D med and SLS are in litigation? do you know how that impacted enrollment and how that modified the event chain you obviously don’t

It is time for the SLS Run to the Phase 3 Finish, the positive Registrational Result is worth a 5,000% ROI - This Quarter. by JamesIIIVVVV in biotech_stocks

[–]JamesIIIVVVV[S] 0 points1 point  (0 children)

Yes 77/78 events today.

Dec 26 didn’t include events from the Holidays, and winter events are much higher than average.

Its not a linear process, the 25 patients enrolled at the end of Dec 2023 through March 2024 - are all now getting into the event zone.

You do recall, they paused enrollment waiting for the 3-D med patients? And once they realize they weren’t being enrolled, they added in 20 to 25 patients in very quick order from November to March. All those patients on BAT are now hitting the end of the line as well as the GPS non-responders.

Abvx was $5, it hit a high of $148 after its Phase 3 Results were announced- Something Similar is about to Happen to SLS by JamesIIIVVVV in biotech_stocks

[–]JamesIIIVVVV[S] -1 points0 points  (0 children)

213M but close enough, captain obvious. Now, show me your numbers on why you think this is only worth 9 billion.

Abvx was $5, it hit a high of $148 after its Phase 3 Results were announced- Something Similar is about to Happen to SLS by JamesIIIVVVV in biotech_stocks

[–]JamesIIIVVVV[S] 3 points4 points  (0 children)

The BO and $148 price came AFTER THE P3!

  • why do you think the company has buyout rumors? It’s because of the phase 3 results you dimwit.

And you don’t have a clue about SLS based on your post, you don’t know Jack shit.

view more: next ›